Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (<scp>AWARD</scp>‐5)

Zachary Skrivanek, Donald A. Berry, Zvonko Miličević et al.|Diabetes Obesity and Metabolism|2014

Cited by 72